Daniel Walter Kaiser
Cardiac Electrophysiology · Nashville
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · Saint Thomas Medical Partners · 588 clinicians in this group
Hospitals listed: Ascension Saint Thomas Hospital · Highpoint Health-Sumner With Ascension Saint Thoma. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Daniel Walter Kaiser’s office at (615) 329-5144 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence A125832 · Cancelled
Licence status: Cancelled · since 2013 · Vanderbilt University School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Tennessee 45583Medical Doctor · since 2009 · expires 2027-02-28Specialty on the licence: Cardiovascular Diseases; Clinical Cardiac Electrophysiology; Internal MedicineLicensedNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
2 placements
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Education
- Vanderbilt Medical School · MDNashville, TN · 2008Medical school
Residency and fellowship
- Internal Medicine, CardiologyNashville, TN · 2009–2010
- Internal Medicine, CardiologyNashville, TN · 2008–2009
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Ascension Saint Thomas HospitalNashville, TNAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Ascension Health, which runs 120 hospitals in 13 statesPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — Death rate among surgical inpatients with serious treatable complications: 223.48 (181.37 to 265.59) · 193 cases, Jul 2022 – Jun 2024Worse than the national rate — SSI - Abdominal Hysterectomy: 2.232, Oct 2024 – Sep 2025Better than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 0.76 (0.56 to 0.97), Jul 2022 – Jun 2024Better than the national rate — Pressure ulcer rate: 0.07 (0 to 0.53) · 10,077 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.452, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.668, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.417, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.458, Oct 2024 – Sep 2025
- Highpoint Health-Sumner With Ascension Saint ThomaGallatin, TNAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Lifepoint Health, which runs 79 hospitals in 21 statesPatients rate it 2 of 5 · 63% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.075, Oct 2024 – Sep 2025
See every measure and the patient survey for Ascension Saint Thomas Hospital
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 4 better, 4 the same, 0 worse of 8 measures. Readmissions: 3 better, 7 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 223.48 (181.37 to 265.59) · 193 cases | Worse | Jul 2022 – Jun 2024 |
| SSI - Abdominal HysterectomyInfections | 2.232 | Worse | Oct 2024 – Sep 2025 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.76 (0.56 to 0.97) | Better | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.07 (0 to 0.53) · 10,077 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.452 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.668 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.417 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.458 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.64 (0 to 1.48) · 2,396 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.6 · 601 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.2 · 139 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.5 · 468 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.1 · 853 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.7 · 698 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.7 · 519 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 7,003 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0.01 to 0.36) · 12,028 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.11 to 0.46) · 12,978 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.21 (1.77 to 4.65) · 4,635 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.58 (0.43 to 2.73) · 2,171 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.53 (0.46 to 2.6) · 4,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.15 (4.75 to 11.56) · 2,189 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.38 (2.77 to 7.99) · 2,129 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.37 (0.02 to 2.72) · 947 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 165 cases | None | Apr 2023 – Mar 2025 |
| SSI - Colon SurgeryInfections | 0.939 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.9 · 634 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 17.4 · 1,157 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -17.6 · 581 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -10.2 · 981 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.4 · 712 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.3 · 916 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 172 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.6 · 574 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.6 · 192 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (9.6 to 16.8) · 323 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.6) · 234 cases | No different | Jan 2024 – Dec 2024 |
What patients said (448 patients answered, 18% of those asked)
| Cleanliness | 2 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Highpoint Health-Sumner With Ascension Saint Thoma
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 4 the same, 0 worse of 6 measures. Readmissions: 1 better, 5 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.075 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.99 (0 to 2.05) · 337 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.27 (0.87 to 1.67) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 150.59 (89.3 to 211.87) · 26 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 86 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 71 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.8 · 223 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.2 · 215 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.2 · 155 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.4 · 2,388 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.02 to 0.46) · 3,405 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.33 (0.12 to 0.54) · 3,338 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.85 (1.42 to 6.29) · 383 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.44 (0 to 3.05) · 84 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.16 (0.49 to 3.83) · 374 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.24 (3.33 to 21.16) · 89 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.68 (1.53 to 9.84) · 82 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.2 to 3.21) · 86 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.22 (0.35 to 2.1) · 2,532 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.464 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 126 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.2 · 505 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 75.5 · 51 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.7 · 259 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -7.6 · 228 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 435 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 234 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (10.1 to 17.3) · 553 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.6) · 136 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,050 patients answered, 20% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 81% |
| Yes, staff "did" give patients information about help after discharge | 79% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 63% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$307,413
Medicare paid this office $307,413 for 947 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 73 | $48,463 | $638 |
| Return visit (30+ min) | 345 | $31,482 | $79 |
| Repair of left upper heart chamber with implant with review by radiologist | 43 | $23,193 | $539 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 93 | $21,946 | $30 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 332 | $19,996 | $19 |
See all 28 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 73 | $48,463 | $638 |
| Return visit (30+ min) | 345 | $31,482 | $79 |
| Repair of left upper heart chamber with implant with review by radiologist | 43 | $23,193 | $539 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 93 | $21,946 | $30 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 332 | $19,996 | $19 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 45 | $18,315 | $52 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 49 | $17,214 | $210 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 409 | $17,056 | $13 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 39 | $13,515 | $347 |
| Programming of dual lead pacemaker system | 225 | $12,964 | $49 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 53 | $12,931 | $209 |
| New patient visit (45+ min) | 94 | $10,170 | $108 |
| Insertion of implantable defibrillator system | 13 | $8,262 | $636 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 72 | $6,617 | $89 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 83 | $6,058 | $23 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 42 | $4,625 | $83 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 420 | $4,601 | $9 |
| Programming of multiple lead implantable defibrillator system | 36 | $2,853 | $73 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $2,514 | $126 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $1,907 | $56 |
| Programming of multiple lead pacemaker system | 22 | $1,303 | $45 |
| Programming of dual lead implantable defibrillator system | 19 | $1,244 | $65 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 62 | $1,166 | $18 |
| Programming of single lead pacemaker system | 16 | $798 | $44 |
| Insertion of heart rhythm monitor under skin | 11 | $609 | $55 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 81 | $520 | $6 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 17 | $290 | $17 |
| Heart rhythm recording of continous external ekg over 8-15 days | 16 | $125 | $8 |
Procedures Medicare counted
| Pacemaker insertion or repair | 88 | More than 97% of doctors who do this |
Who their Medicare patients are
947 Original Medicare patients in 2024. Average age 77 · Under 65 3% · 85 and older 17% · Women 46% · Also on Medicaid 7% · Health risk score 1.63. At or below the middle of the specialty; the typical clinical cardiac electrophysiology clinician is at 1.8.
Conditions among them: High blood pressure 75% · Atrial fibrillation 68% · Coronary heart disease 53% · Heart failure 44% · Chronic kidney disease 37% · Diabetes 36% · Depression 22% · COPD 20% · Cancer 17% · Stroke 15% · Dementia 9%.
The office billed $989,665, Medicare allowed $411,314 and paid $307,413; for 5,923 services of 63 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 947 | 5,923 | 77 | 1.63 | $989,665 | $307,413 |
| 2023 | 849 | 6,329 | 77 | 1.54 | $992,039 | $317,030 |
| 2022 | 955 | 6,756 | 77 | 1.57 | $1,118,938 | $347,689 |
| 2021 | 856 | 4,155 | 76 | 1.60 | $839,655 | $295,656 |
| 2020 | 407 | 1,890 | 75 | 1.64 | $498,986 | $180,176 |
| 2019 | 697 | 1,761 | 76 | 1.86 | $575,777 | $188,474 |
| 2018 | 607 | 1,882 | 77 | 1.90 | $608,088 | $198,755 |
| 2017 | 796 | 1,886 | 78 | 1.97 | $681,814 | $181,359 |
| 2016 | 277 | 691 | 77 | 1.83 | $341,713 | $93,889 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 30 services
| Repair of left upper heart chamber with implant with review by radiologist | 75 | $41,527 | $554 |
| Return visit (30+ min) | 332 | $35,629 | $83 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 135 | $35,010 | $39 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 46 | $30,393 | $661 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 260 | $16,477 | $20 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 338 | $14,896 | $14 |
| Insertion of implantable defibrillator system | 21 | $13,483 | $642 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 37 | $13,161 | $356 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 96 | $12,192 | $17 |
| Programming of dual lead pacemaker system | 172 | $10,523 | $51 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 41 | $10,055 | $209 |
| New patient visit (45+ min) | 78 | $8,621 | $111 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 55 | $7,281 | $87 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 46 | $6,705 | $17 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 67 | $6,602 | $92 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 23 | $6,339 | $219 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 82 | $5,351 | $23 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 16 | $5,269 | $329 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 389 | $4,789 | $10 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $4,132 | $129 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 41 | $2,766 | $58 |
| Programming of multiple lead implantable defibrillator system | 31 | $2,317 | $64 |
| Programming of dual lead implantable defibrillator system | 26 | $1,809 | $62 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 80 | $1,483 | $19 |
| Programming of multiple lead pacemaker system | 23 | $1,451 | $58 |
| External shock to heart to regulate heart beat | 11 | $877 | $80 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 54 | $844 | $16 |
| Heart rhythm recording of continous external ekg over 8-15 days | 21 | $169 | $8 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 11 | $85 | $8 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 12 | $73 | $5 |
2022: 31 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 58 | $46,391 | $800 |
| Return visit (30+ min) | 426 | $44,746 | $81 |
| Repair of left upper heart chamber with implant with review by radiologist | 70 | $39,581 | $565 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 52 | $18,876 | $363 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 251 | $14,546 | $20 |
| Insertion of implantable defibrillator system | 21 | $13,905 | $662 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 329 | $13,761 | $15 |
| Programming of dual lead pacemaker system | 180 | $12,065 | $55 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 100 | $11,886 | $18 |
| New patient visit (45+ min) | 102 | $11,845 | $116 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 45 | $11,081 | $226 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 146 | $10,688 | $11 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 87 | $9,226 | $98 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 59 | $8,557 | $17 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 14 | $7,662 | $547 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 59 | $7,258 | $76 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 20 | $6,775 | $339 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 81 | $6,695 | $52 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 27 | $6,545 | $226 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 505 | $6,241 | $9 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 81 | $5,260 | $25 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $4,180 | $131 |
| Programming of multiple lead implantable defibrillator system | 39 | $3,755 | $74 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 93 | $1,808 | $19 |
| Programming of dual lead implantable defibrillator system | 22 | $1,807 | $72 |
| Programming of multiple lead pacemaker system | 23 | $1,661 | $55 |
| Return visit (30+ min) | 12 | $1,052 | $66 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 60 | $1,051 | $17 |
| Heart rhythm recording of continous external ekg over 8-15 days | 27 | $264 | $10 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 17 | $163 | $9 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 12 | $81 | $5 |
2021: 41 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 44 | $35,787 | $813 |
| Return visit (30+ min) | 180 | $22,188 | $95 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 48 | $18,193 | $379 |
| Repair of left upper heart chamber with implant with review by radiologist | 31 | $17,636 | $569 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 62 | $13,529 | $218 |
| New patient visit (60+ min) | 83 | $13,126 | $158 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 77 | $10,060 | $79 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 61 | $9,533 | $149 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 15 | $9,130 | $609 |
| Long return visit (40+ min) | 60 | $8,885 | $135 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 291 | $8,400 | $18 |
| Programming of dual lead pacemaker system | 114 | $8,383 | $54 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 228 | $8,299 | $22 |
| Insertion of implantable defibrillator system | 12 | $8,277 | $690 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 23 | $7,958 | $318 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 94 | $7,514 | $54 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 23 | $7,316 | $318 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 62 | $6,388 | $98 |
| New patient visit (45+ min) | 52 | $6,368 | $122 |
| Short return visit (20+ min) | 100 | $5,660 | $51 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 367 | $5,603 | $10 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 96 | $5,362 | $20 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 13 | $4,565 | $351 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 62 | $4,194 | $19 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 138 | $4,051 | $13 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 47 | $4,012 | $85 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 64 | $2,913 | $28 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 22 | $1,940 | $88 |
| Programming of multiple lead implantable defibrillator system | 21 | $1,906 | $76 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 76 | $1,461 | $19 |
| Programming of multiple lead pacemaker system | 17 | $1,348 | $59 |
| New patient visit (45+ min) | 12 | $1,285 | $107 |
| Programming of dual lead implantable defibrillator system | 16 | $1,272 | $67 |
| Programming of heart rhythm stimulation after drug infusion | 13 | $1,233 | $95 |
| Return visit (30+ min) | 14 | $1,156 | $77 |
| Insertion of heart rhythm monitor under skin | 16 | $1,056 | $66 |
| External shock to heart to regulate heart beat | 11 | $927 | $84 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 48 | $866 | $18 |
| Heart rhythm recording of continous external ekg over 8-15 days | 19 | $198 | $10 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 14 | $132 | $9 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 14 | $97 | $6 |
2020: 25 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 32 | $27,230 | $825 |
| Repair of left upper heart chamber with implant with review by radiologist | 24 | $14,412 | $601 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 34 | $12,366 | $364 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 46 | $10,442 | $222 |
| New patient visit (45+ min) | 85 | $10,376 | $122 |
| Short return visit (20+ min) | 140 | $9,634 | $54 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 71 | $8,683 | $56 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 13 | $8,164 | $628 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 24 | $7,613 | $317 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 44 | $6,700 | $152 |
| Return visit (30+ min) | 70 | $6,454 | $80 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 54 | $5,891 | $107 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 220 | $4,274 | $12 |
| Programming of dual lead pacemaker system | 54 | $3,954 | $49 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 34 | $3,844 | $110 |
| New patient visit (60+ min) | 25 | $3,658 | $146 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $2,136 | $79 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 44 | $1,947 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 55 | $1,912 | $18 |
| Insertion of artery tube for blood sampling or infusion through skin | 47 | $1,821 | $35 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 75 | $1,615 | $20 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 17 | $1,540 | $91 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 15 | $686 | $21 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 11 | $607 | $25 |
| External ekg recording for more than 48 hours up to 21 days | 22 | $209 | $9 |
2019: 25 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 35 | $32,868 | $913 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 34 | $13,340 | $392 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 55 | $13,333 | $238 |
| Insertion of implantable defibrillator system | 15 | $10,853 | $724 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 17 | $10,813 | $636 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 28 | $9,497 | $339 |
| New patient visit (60+ min) | 47 | $7,486 | $159 |
| Short return visit (20+ min) | 98 | $7,027 | $58 |
| Return visit (30+ min) | 71 | $6,943 | $86 |
| Repair of left upper heart chamber with implant with review by radiologist | 14 | $5,897 | $421 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 14 | $5,355 | $357 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 13 | $4,960 | $382 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 39 | $4,901 | $123 |
| New patient visit (45+ min) | 39 | $4,751 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 45 | $4,557 | $56 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 40 | $4,429 | $111 |
| Programming of dual lead pacemaker system | 49 | $3,334 | $52 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 333 | $3,262 | $8 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 151 | $2,880 | $14 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 24 | $1,864 | $75 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 19 | $1,709 | $90 |
| Programming of dual lead implantable defibrillator system | 16 | $1,362 | $65 |
| Return visit (30+ min) | 11 | $665 | $60 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 20 | $550 | $26 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 14 | $149 | $11 |
2018: 26 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 42 | $38,314 | $912 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 57 | $15,310 | $269 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 37 | $12,658 | $342 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 28 | $12,026 | $429 |
| Return visit (30+ min) | 79 | $11,628 | $93 |
| Short return visit (20+ min) | 101 | $10,537 | $61 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 13 | $9,223 | $709 |
| Insertion of implantable defibrillator system | 11 | $8,308 | $755 |
| New patient visit (45+ min) | 58 | $8,132 | $140 |
| New patient visit (60+ min) | 42 | $7,428 | $177 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 45 | $5,544 | $123 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 179 | $5,435 | $15 |
| Repair of left upper heart chamber with implant with review by radiologist | 12 | $5,019 | $418 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 11 | $4,340 | $395 |
| Programming of dual lead pacemaker system | 40 | $3,448 | $51 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 327 | $2,960 | $8 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,480 | $118 |
| Programming of multiple lead implantable defibrillator system | 15 | $2,293 | $72 |
| Programming of dual lead implantable defibrillator system | 17 | $2,045 | $62 |
| External shock to heart to regulate heart beat | 17 | $1,944 | $97 |
| Programming of heart rhythm stimulation after drug infusion | 12 | $1,482 | $124 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 13 | $1,304 | $100 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 28 | $1,221 | $27 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 17 | $1,175 | $47 |
| Evaluation of implantable heart and blood vessel monitoring system | 14 | $488 | $29 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 29 | $322 | $11 |
2017: 25 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 36 | $35,290 | $954 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 52 | $18,019 | $340 |
| Return visit (30+ min) | 104 | $14,367 | $94 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 25 | $10,799 | $432 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 15 | $10,635 | $709 |
| Short return visit (20+ min) | 103 | $9,852 | $60 |
| Insertion of implantable defibrillator system | 12 | $9,348 | $779 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 23 | $8,307 | $361 |
| Long return visit (40+ min) | 39 | $5,414 | $135 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 37 | $4,904 | $129 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 537 | $4,630 | $7 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 11 | $4,412 | $401 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 145 | $3,924 | $15 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,175 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $2,084 | $87 |
| Programming of dual lead pacemaker system | 32 | $2,022 | $52 |
| External shock to heart to regulate heart beat | 14 | $1,705 | $100 |
| Programming of multiple lead implantable defibrillator system | 14 | $1,541 | $77 |
| New patient visit (30+ min) | 15 | $1,360 | $91 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 13 | $1,323 | $102 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,166 | $65 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 11 | $693 | $58 |
| Evaluation of implantable heart and blood vessel monitoring system | 15 | $565 | $25 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $559 | $35 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 39 | $445 | $11 |
2016: 9 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 25 | $24,109 | $964 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 30 | $10,192 | $340 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 21 | $7,588 | $361 |
| Long return visit (40+ min) | 38 | $5,246 | $135 |
| Return visit (30+ min) | 40 | $4,677 | $100 |
| Short return visit (20+ min) | 39 | $3,646 | $68 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 25 | $3,206 | $128 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 81 | $1,674 | $16 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 141 | $1,290 | $8 |
Medicaid work
$7,007 in 2024
Medicaid paid $7,007 for 1,033 billed services this clinician did in 2024, up to 35 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 327 | $1,824 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, including analysis of 1 or more recorded physiologic cardiovascular data elements from all internal and external sensors, analysis, review(s) and report(s) by a physician or other qualified health care professional | 324 | $1,739 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead implantable defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 114 | $1,463 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 131 | $933 |
| Interrogation device evaluation(s), (remote) up to 30 days; subcutaneous cardiac rhythm monitor system, including analysis of recorded heart rhythm data, analysis, review(s) and report(s) by a physician or other qualified health care professional | 81 | $830 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 34 | $115 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 22 | $103 |
| 2024 | 1,033 | 7 | 35 | $7,007 |
| 2023 | 1,502 | 12 | 36 | $9,879 |
| 2022 | 1,441 | 8 | 35 | $11,551 |
| 2021 | 428 | 7 | 43 | $3,330 |
| 2020 | 59 | 1 | 16 | $304 |
| 2019 | 132 | 1 | 61 | $518 |
| 2018 | 146 | 2 | 57 | $874 |
See the largest Medicaid services in earlier years
2023
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 411 | $3,189 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, including analysis of 1 or more recorded physiologic cardiovascular data elements from all internal and external sensors, analysis, review(s) and report(s) by a physician or other qualified health care professional | 416 | $2,055 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 333 | $1,925 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead implantable defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 112 | $1,588 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 92 | $586 |
| Return visit (30+ min) | 29 | $241 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 35 | $197 |
| Interrogation device evaluation(s), (remote) up to 30 days; subcutaneous cardiac rhythm monitor system, including analysis of recorded heart rhythm data, analysis, review(s) and report(s) by a physician or other qualified health care professional | 14 | $97 |
| TOBACCO NON-USER | 15 | $0 |
| Medication list documented in medical record (COA) | 16 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 16 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 13 | $0 |
2022
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 422 | $4,852 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, including analysis of 1 or more recorded physiologic cardiovascular data elements from all internal and external sensors, analysis, review(s) and report(s) by a physician or other qualified health care professional | 392 | $2,103 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 307 | $1,557 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead implantable defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 81 | $1,186 |
| Return visit (30+ min) | 67 | $956 |
| Interrogation device evaluation(s), (remote) up to 30 days; subcutaneous cardiac rhythm monitor system, including analysis of recorded heart rhythm data, analysis, review(s) and report(s) by a physician or other qualified health care professional | 34 | $369 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 78 | $286 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 60 | $242 |
2021
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 110 | $1,065 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, including analysis of 1 or more recorded physiologic cardiovascular data elements from all internal and external sensors, analysis, review(s) and report(s) by a physician or other qualified health care professional | 123 | $702 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead implantable defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 33 | $641 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 103 | $560 |
| Interrogation device evaluation(s), (remote) up to 30 days; subcutaneous cardiac rhythm monitor system, including analysis of recorded heart rhythm data, analysis, review(s) and report(s) by a physician or other qualified health care professional | 15 | $149 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 25 | $121 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 19 | $92 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 59 | $304 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 132 | $518 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 13 | $442 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 133 | $432 |
Drugs they prescribed that Part D paid
$1,005,774
Pharmacies billed $1,005,774 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 3,458) in 2024. At or below the middle of the specialty; the typical clinical cardiac electrophysiology clinician is at 0%.
2,550 generic and 908 brand-name prescriptions · $1,005,774 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 685 | $709,892 | $1,036 |
| Xarelto | 141 | $167,298 | $1,187 |
| Flecainide Acetate | 461 | $20,453 | $44 |
| Entresto | 11 | $16,551 | $1,505 |
| Ozempic | 13 | $11,847 | $911 |
See all 29 drugs
| Eliquis | 685 | $709,892 | $1,036 |
| Xarelto | 141 | $167,298 | $1,187 |
| Flecainide Acetate | 461 | $20,453 | $44 |
| Entresto | 11 | $16,551 | $1,505 |
| Ozempic | 13 | $11,847 | $911 |
| Metoprolol | 661 | $10,795 | $16 |
| Dofetilide | 46 | $10,207 | $222 |
| Amiodarone | 311 | $8,034 | $26 |
| Farxiga | 13 | $7,584 | $583 |
| Repatha Sureclick | 13 | $7,094 | $546 |
| Sotalol | 176 | $3,636 | $21 |
| Diltiazem 24hr Er (Cd) | 104 | $2,863 | $28 |
| Ranolazine Er | 18 | $1,634 | $91 |
| Atorvastatin | 112 | $1,386 | $12 |
| Nebivolol | 11 | $1,093 | $99 |
| Clopidogrel | 50 | $721 | $14 |
| Metoprolol | 133 | $669 | $5 |
| Carvedilol | 76 | $538 | $7 |
| Valsartan | 15 | $484 | $32 |
| Torsemide | 26 | $421 | $16 |
| Potassium Chloride | 39 | $387 | $10 |
| Furosemide | 59 | $337 | $6 |
| Losartan | 27 | $320 | $12 |
| Digoxin | 15 | $309 | $21 |
| Spironolactone | 33 | $302 | $9 |
| Rosuvastatin | 15 | $172 | $11 |
| Amlodipine Besylate | 21 | $118 | $6 |
| Warfarin | 12 | $82 | $7 |
| Lisinopril | 21 | $68 | $3 |
Year by year
| 2024 | 3,458 | 736 | 0% (0) | 26% | $1,005,774 |
| 2023 | 3,161 | 642 | 0% (0) | 27% | $965,133 |
| 2022 | 2,770 | 604 | 0% (0) | 28% | $795,584 |
| 2021 | 1,876 | 437 | 0% (0) | 27% | $416,705 |
| 2020 | 889 | 223 | None | 25% | $153,208 |
| 2019 | 391 | 124 | None | 21% | $58,321 |
| 2018 | 471 | 99 | None | 22% | $54,938 |
| 2017 | 425 | 95 | None | 24% | $40,684 |
| 2016 | 97 | 44 | None | 23% | $12,095 |
| 2014 | 45 | None | None | None | $613 |
| 2013 | 68 | 24 | 27% (18) | None | $1,109 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 26 drugs
| Eliquis | 638 | $627,447 | $983 |
| Xarelto | 165 | $189,515 | $1,149 |
| Flecainide Acetate | 350 | $22,078 | $63 |
| Entresto | 11 | $15,454 | $1,405 |
| Metoprolol | 541 | $14,443 | $27 |
| Dofetilide | 47 | $13,882 | $295 |
| Amiodarone | 257 | $10,609 | $41 |
| Sotalol | 192 | $6,866 | $36 |
| Repatha Sureclick | 11 | $6,454 | $587 |
| Diltiazem 24hr Er (Cd) | 131 | $4,284 | $33 |
| Ranolazine Er | 25 | $2,630 | $105 |
| Atorvastatin | 136 | $2,331 | $17 |
| Metoprolol | 116 | $1,324 | $11 |
| Nebivolol | 11 | $1,150 | $105 |
| Torsemide | 34 | $880 | $26 |
| Clopidogrel | 42 | $876 | $21 |
| Carvedilol | 76 | $691 | $9 |
| Losartan | 48 | $660 | $14 |
| Fludrocortisone Acetate | 11 | $520 | $47 |
| Spironolactone | 38 | $504 | $13 |
| Bisoprolol | 11 | $489 | $44 |
| Potassium Chloride | 13 | $359 | $28 |
| Furosemide | 48 | $312 | $7 |
| Warfarin | 13 | $162 | $12 |
| Lisinopril | 18 | $105 | $6 |
| Amlodipine Besylate | 24 | $81 | $3 |
2022: 25 drugs
| Eliquis | 527 | $501,229 | $951 |
| Xarelto | 159 | $164,076 | $1,032 |
| Flecainide Acetate | 325 | $21,039 | $65 |
| Entresto | 15 | $13,653 | $910 |
| Metoprolol | 409 | $10,771 | $26 |
| Dofetilide | 42 | $10,696 | $255 |
| Amiodarone | 231 | $9,954 | $43 |
| Sotalol | 168 | $4,156 | $25 |
| Diltiazem 24hr Er (Cd) | 85 | $3,270 | $38 |
| Ranolazine Er | 15 | $2,917 | $194 |
| Atorvastatin | 62 | $1,216 | $20 |
| Metoprolol | 119 | $1,127 | $9 |
| Losartan | 62 | $791 | $13 |
| Clopidogrel | 29 | $698 | $24 |
| Carvedilol | 58 | $673 | $12 |
| Torsemide | 38 | $644 | $17 |
| Spironolactone | 63 | $600 | $10 |
| Diltiazem | 14 | $479 | $34 |
| Furosemide | 56 | $331 | $6 |
| Potassium Chloride | 14 | $316 | $23 |
| Digoxin | 14 | $302 | $22 |
| Warfarin | 18 | $174 | $10 |
| Lisinopril | 19 | $100 | $5 |
| Amlodipine Besylate | 26 | $78 | $3 |
| Hydrochlorothiazide | 15 | $71 | $5 |
2021: 22 drugs
| Eliquis | 410 | $287,687 | $702 |
| Xarelto | 50 | $51,973 | $1,039 |
| Flecainide Acetate | 244 | $15,961 | $65 |
| Amiodarone | 207 | $6,983 | $34 |
| Metoprolol | 235 | $4,928 | $21 |
| Pacerone | 33 | $3,803 | $115 |
| Sotalol | 98 | $2,528 | $26 |
| Diltiazem 24hr Er (Cd) | 33 | $1,265 | $38 |
| Losartan | 55 | $609 | $11 |
| Metoprolol | 92 | $578 | $6 |
| Torsemide | 39 | $539 | $14 |
| Atorvastatin | 28 | $472 | $17 |
| Sotalol Af | 12 | $378 | $32 |
| Carvedilol | 31 | $315 | $10 |
| Spironolactone | 28 | $246 | $9 |
| Digoxin | 14 | $244 | $17 |
| Clopidogrel | 19 | $219 | $12 |
| Furosemide | 33 | $209 | $6 |
| Lisinopril | 21 | $206 | $10 |
| Potassium Chloride | 16 | $199 | $12 |
| Amlodipine Besylate | 11 | $61 | $6 |
| Hydrochlorothiazide | 12 | $52 | $4 |
2020: 16 drugs
| Eliquis | 151 | $89,676 | $594 |
| Xarelto | 29 | $27,018 | $932 |
| Multaq | 13 | $9,349 | $719 |
| Flecainide Acetate | 144 | $8,973 | $62 |
| Amiodarone | 98 | $2,047 | $21 |
| Metoprolol | 108 | $1,907 | $18 |
| Sotalol | 39 | $871 | $22 |
| Atorvastatin | 35 | $506 | $14 |
| Torsemide | 29 | $369 | $13 |
| Metoprolol | 50 | $350 | $7 |
| Diltiazem 24hr Er (Cd) | 12 | $299 | $25 |
| Warfarin | 11 | $191 | $17 |
| Losartan | 21 | $185 | $9 |
| Carvedilol | 14 | $139 | $10 |
| Spironolactone | 13 | $131 | $10 |
| Furosemide | 15 | $72 | $5 |
2019: 8 drugs
| Eliquis | 49 | $33,424 | $682 |
| Entresto | 14 | $12,359 | $883 |
| Metoprolol | 67 | $1,897 | $28 |
| Flecainide Acetate | 52 | $1,335 | $26 |
| Amiodarone | 15 | $444 | $30 |
| Losartan | 45 | $365 | $8 |
| Sotalol | 19 | $284 | $15 |
| Furosemide | 12 | $43 | $4 |
2018: 14 drugs
| Eliquis | 41 | $23,260 | $567 |
| Entresto | 23 | $13,457 | $585 |
| Xarelto | 12 | $10,281 | $857 |
| Flecainide Acetate | 67 | $1,842 | $27 |
| Metoprolol | 52 | $1,825 | $35 |
| Losartan | 53 | $741 | $14 |
| Amiodarone | 28 | $609 | $22 |
| Cartia Xt | 13 | $484 | $37 |
| Atorvastatin | 15 | $286 | $19 |
| Diltiazem 24hr Er (Cd) | 16 | $234 | $15 |
| Losartan-Hydrochlorothiazide | 18 | $166 | $9 |
| Carvedilol | 14 | $146 | $10 |
| Furosemide | 17 | $89 | $5 |
| Amlodipine Besylate | 13 | $48 | $4 |
2017: 12 drugs
| Eliquis | 21 | $11,757 | $560 |
| Xarelto | 23 | $11,515 | $501 |
| Entresto | 14 | $6,860 | $490 |
| Flecainide Acetate | 55 | $1,836 | $33 |
| Metoprolol | 47 | $1,251 | $27 |
| Amiodarone | 27 | $1,078 | $40 |
| Losartan | 33 | $307 | $9 |
| Atorvastatin | 20 | $239 | $12 |
| Carvedilol | 20 | $121 | $6 |
| Furosemide | 27 | $109 | $4 |
| Lisinopril | 22 | $93 | $4 |
| Clopidogrel | 13 | $80 | $6 |
2016: 3 drugs
| Xarelto | 13 | $7,199 | $554 |
| Flecainide Acetate | 14 | $425 | $30 |
| Cephalexin | 13 | $74 | $6 |
2013: 2 drugs
| Hydrocodone-Acetaminophen | 18 | $215 | $12 |
| Cephalexin | 11 | $54 | $5 |
Money from drug and device companies
$4,597 in 2025
| 2025 | 4 | 65 | None | $4,597 |
| 2024 | 10 | 80 | None | $5,393 |
| 2023 | 11 | 59 | None | $2,883 |
| 2022 | 7 | 41 | None | $2,323 |
| 2021 | 5 | 23 | $2,900 | $4,139 |
| 2020 | 3 | 19 | None | $1,047 |
| 2019 | 9 | 73 | $900 | $5,443 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Farapulse | $3,681 | 38 payments
|
| Medtronic | Micra | $472 | 24 payments
|
| Abbott Laboratories | Ensite | $423 | 2 payments
|
| AtriCure | Atriclip Laa Exclusion System | $20 | 1 payment
|
See all 65 published payments
| Boston Scientific | Meals · 2025-12-18 | Watchman Flx | $9 |
| Medtronic | Meals · 2025-12-10 | Micra | $5 |
| Medtronic | Meals · 2025-12-10 | Micra | $18 |
| Boston Scientific | Meals · 2025-12-04 | Watchman Flx | $6 |
| Medtronic | Meals · 2025-12-03 | Cobalt Dr Mri Surescan | $3 |
| Boston Scientific | Meals · 2025-11-20 | Watchman Access System | $43 |
| Abbott Laboratories | Meals · 2025-11-20 | Ensite | $217 |
| Boston Scientific | Meals · 2025-10-13 | General - Ep | $6 |
| Medtronic | Meals · 2025-10-08 | Cobalt Dr Mri Surescan | $3 |
| Boston Scientific | Meals · 2025-10-04 | Farapulse | $455 |
| Boston Scientific | Travel · 2025-10-04 | Farapulse | $377 |
| Boston Scientific | Meals · 2025-10-03 | Farapulse | $23 |
| Boston Scientific | Meals · 2025-10-03 | Farapulse | $550 |
| Boston Scientific | Travel · 2025-10-03 | Farapulse | $377 |
| Boston Scientific | Meals · 2025-10-02 | Farapulse | $10 |
| Boston Scientific | Travel · 2025-10-02 | Farapulse | $377 |
| Boston Scientific | Travel · 2025-10-02 | Farapulse | $522 |
| Medtronic | Meals · 2025-09-30 | Micra | $6 |
| Medtronic | Meals · 2025-09-12 | Micra | $18 |
| Boston Scientific | Meals · 2025-09-10 | Bodyguardian | $7 |
| Boston Scientific | Meals · 2025-09-09 | Farapulse | $109 |
| Medtronic | Meals · 2025-09-05 | Cobalt Dr Mri Surescan | $42 |
| Medtronic | Meals · 2025-09-03 | Micra | $4 |
| Boston Scientific | Meals · 2025-08-31 | Farapulse | $18 |
| Boston Scientific | Meals · 2025-08-30 | Watchman Flx | $10 |
| Medtronic | Meals · 2025-08-21 | Micra | $7 |
| Boston Scientific | Meals · 2025-08-12 | Farapulse | $35 |
| Boston Scientific | Meals · 2025-08-10 | Bodyguardian | $30 |
| Boston Scientific | Meals · 2025-08-10 | Bodyguardian | $14 |
| Boston Scientific | Meals · 2025-07-26 | Watchman Flx | $13 |
| Boston Scientific | Meals · 2025-07-25 | Watchman Flx | $4 |
| Abbott Laboratories | Meals · 2025-07-24 | Ensite Precision | $206 |
| Boston Scientific | Meals · 2025-07-17 | Farapulse | $32 |
| Medtronic | Meals · 2025-06-25 | Cobalt Dr Mri Surescan | $19 |
| Medtronic | Meals · 2025-06-22 | Micra | $56 |
| Boston Scientific | Meals · 2025-06-20 | Watchman Access System | $28 |
| Medtronic | Meals · 2025-06-18 | Cobalt Dr Mri Surescan | $7 |
| Boston Scientific | Meals · 2025-06-17 | Farapulse | $29 |
| Medtronic | Meals · 2025-06-11 | Micra | $20 |
| Boston Scientific | Meals · 2025-06-07 | Watchman Flx | $16 |
| Boston Scientific | Meals · 2025-06-06 | Farapulse | $6 |
| Medtronic | Meals · 2025-06-04 | Azure Xt Dr Mri Surescan | $18 |
| Boston Scientific | Meals · 2025-05-15 | Watchman Flx | $149 |
| Medtronic | Meals · 2025-05-01 | Cobalt Dr Mri Surescan | $6 |
| Boston Scientific | Meals · 2025-04-27 | Farapulse | $168 |
| Medtronic | Meals · 2025-04-26 | Micra | $119 |
| Medtronic | Meals · 2025-04-26 | None | $57 |
| Medtronic | Meals · 2025-04-26 | Micra | $11 |
| Boston Scientific | Meals · 2025-04-25 | Farapulse | $57 |
| Boston Scientific | Meals · 2025-04-25 | General - Therapies | $38 |
| Boston Scientific | Meals · 2025-04-24 | General - Therapies | $75 |
| Boston Scientific | Meals · 2025-04-10 | Farapulse | $35 |
| Medtronic | Meals · 2025-03-14 | Micra | $6 |
| Medtronic | Meals · 2025-03-13 | Micra | $17 |
| Boston Scientific | Meals · 2025-03-03 | Farapulse | $7 |
| Medtronic | Meals · 2025-02-28 | Micra | $7 |
| AtriCure | Meals · 2025-02-25 | Atriclip Laa Exclusion System | $20 |
| Medtronic | Meals · 2025-02-21 | Cobalt Dr Mri Surescan | $6 |
| Boston Scientific | Meals · 2025-02-20 | Farapulse | $6 |
| Medtronic | Meals · 2025-02-19 | Cobalt Dr Mri Surescan | $9 |
| Boston Scientific | Meals · 2025-02-18 | Watchman Flx | $8 |
| Boston Scientific | Meals · 2025-02-18 | Watchman Flx | $5 |
| Medtronic | Meals · 2025-02-18 | Micra | $9 |
| Boston Scientific | Meals · 2025-02-06 | Emblem Mri S-Icd | $4 |
| Boston Scientific | Meals · 2025-01-09 | Farapulse | $23 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $5,393
| Boston Scientific | Watchman Flx | $4,119 | 50 payments
|
| Medtronic | Micra | $381 | 9 payments
|
| Janssen Pharmaceuticals | Xarelto | $375 | 10 payments
|
| Abbott Laboratories | Thoratec Heartmate 3 Lvas Implant Kit | $240 | 2 payments
|
| Heartflow | Ffrct | $124 | 1 payment
|
| Novo Nordisk | Ozempic | $63 | 3 payments
|
| Actelion Pharmaceuticals US | Uptravi | $30 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $24 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $20 | 1 payment
|
| Scpharmaceuticals | Furoscix | $19 | 1 payment
|
2023: $2,883
| Boston Scientific | Watchman Access System | $1,458 | 31 payments
|
| Medtronic | Arctic Front Advance | $511 | 8 payments
|
| Abbott Laboratories | Ensite Precision | $406 | 3 payments
|
| Novo Nordisk | Wegovy | $177 | 4 payments
|
| Janssen Pharmaceuticals | Xarelto | $115 | 6 payments
|
| Biosense Webster | Carto 3 | $113 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $33 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $24 | 1 payment
|
| Aziyo Biologics | Ecm Patch,Pouch | $18 | 1 payment
|
| Sanofi-Aventis U.S. | Multaq | $14 | 1 payment
|
| Scpharmaceuticals | Furoscix | $14 | 1 payment
|
2022: $2,323
| Boston Scientific | Watchman Access System | $1,428 | 24 payments
|
| Abbott Laboratories | Ensite Precision | $364 | 2 payments
|
| Medtronic | Micra | $248 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $209 | 9 payments
|
| Aziyo Biologics | Ecm Patch,Pouch | $33 | 1 payment
|
| Bardy Diagnostics | Carnation Ambulatory Monitor | $22 | 1 payment
|
| Novo Nordisk | Ozempic | $20 | 1 payment
|
2021: $4,139
| Abbott Laboratories | Ensite Precision Cardiac Mapping System | $3,224 | 5 payments
|
| Boston Scientific | Vigilant | $814 | 15 payments
|
| Medtronic | Micra | $55 | 1 payment
|
| CVRx | Barostim Neo System | $28 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $18 | 1 payment
|
2020: $1,047
| Boston Scientific | Watchman | $605 | 14 payments
|
| Abbott Laboratories | Xience Sierra Coronary Stent System | $400 | 3 payments
|
| Bardy Diagnostics | Carnation Ambulatory Monitor | $42 | 2 payments
|
2019: $5,443
| Abbott Laboratories | Ensite Cardiac Mapping System | $2,449 | 24 payments
|
| Boston Scientific | General Therapies | $2,005 | 29 payments
|
| Medtronic Vascular | Azure | $589 | 12 payments
|
| Biotronik | None | $219 | 3 payments
|
| CardioFocus | None | $118 | 1 payment
|
| Braemar Manufacturing | Cardiac Monitoring Suite | $22 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $16 | 1 payment
|
| Amgen | Corlanor | $14 | 1 payment
|
| Corcept Therapeutics | Korlym | $12 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| ATRICURE, INC. · A Multicenter Patient Registry for Outcomes From Comprehensive Ablation Treatments of Atrial Arrhythmias · 2023 | Their institution | $30,000 |
| Medtronic, Inc. · Investigator Sponsored Research · 2024 | Their institution | $28,092 |
| CVRx, Inc. · Barostim Neo System · 2019 | Their institution | $22,855 |
| Medtronic, Inc. · Investigator Sponsored Research · 2023 | Their institution | $18,794 |
| Abbott Laboratories · Sjm Brady Mri Post Approval Study · 2019 | Their institution | $10,932 |
| Abbott Laboratories · Sjm Brady Mri Post Approval Study · 2020 | Their institution | $1,565 |
| ATRICURE, INC. · Pivotal Study of A Dual Epicardial & Endocardial Procedure Deep Approach for Treatment of Subjects With Persistent Or Long Standing Persistent Atrial Fibrillation With Radiofrequency Ablation · 2023 | Their institution | $700 |
| ATRICURE, INC. · Pivotal Study of A Dual Epicardial & Endocardial Procedure (Deep) Approach for Treatment of Subjects With Persistent Or Long Standing Persistent Atrial Fibrillation With Radiofrequency Ablation · 2022 | Their institution | $200 |
Professional record
- NPI
- 1972777480
- Licence
- CA A125832, TN 45583California A125832: CancelledTennessee 45583: Licensed
- Trained
- Vanderbilt University School of Medicine, 2008
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RC0001X (207RC0001X); Cardiology (207RC0000X)
- Mailing address
- 6 Woodland Rd Ste 304, Saint Helena, CA, 94574
- NPI first listed
- 2008-04-15
- NPI last updated
- 2020-01-14
- NPI record certified
- 2020-01-14
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2490 Hospital Dr Ste 104, Mountain View, CA, 94040 · 2601 Tvc, Nashville, TN, 37232 · 6 Woodland Rd Ste 304, Saint Helena, CA, 94574